Skip to main content
Home Press Releases

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2025/02/vq-vert-color-linkedin-size.png

VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP

VQ Biomedical is a Duke University start-up and DCP portfolio company resulting from the collaboration Duke clinicians and engineers.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/avalo-logo-featured-image.png

Durham agtech startup Avalo secures $11M in funding

Avalo is a Duke agtech start-up based on technology developed by former postdoc Mariano Alvarez (Biology, Trinity) and Professor Cynthia Rudin (CS, Trinity).

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/nai-patent-2024-story-featured-image.png

Duke University ranks 24th worldwide for patents granted to academic institutions

Duke researchers are pioneering inventors and Duke is successfully commercializing these inventions for the benefit of the public.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/mcdonnell-baxter-award-featured.png

Donald Patrick McDonnell, PhD, Wins 2025 Baxter Prize for Entrepreneurship

Professor Donald McDonnell (PCB, SOM) is a serial inventor with multiple commercialized technologies, including FDA-approved breast cancer drug ORSERDU.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/mchutchison-featured.png

Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board

New Tune CEO John McHutchison has held professorships and associate directorships at SOM and DCRI. Tune is a Duke spinout and DCP portfolio company.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/lumotive-logo-featured-image.png

Lumotive Raises $45 Million to Expand Sales of Programmable Optical Semiconductors

Lumotive is a metamaterials start-up spun out of the labs of Professor David Smith and Associate Professor Maiken Mikkelsen (ECE, Pratt). Mikkelsen's former postdoc Gleb Akselrod is the founder and CTO.

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/jim-flatt-wide.png

Dr. Jim Flatt Announced as New CEO of DMC Biotechnologies

DMC Technologies is a Duke start-up commercializing sustainable chemistry technology out of the lab of Associate Professor Michael Lynch (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/tune-therapeutics-large.png

Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs

Tune Therapeutics is a Duke University start-up and Duke Capital Partners portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/vividion-tavros-acquisition.png

Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform

Tavros Therapeutics was co-founded by Eoin McDonnell, graduate of the Duke University Molecular Cancer Biology PhD Program, and Associate Professor Kris Wood (Pharmacology and Cancer Biology, SOM).

Read More

1 2 3 33